查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1585766

骨形成蛋白市场：依类型、应用分类 - 2025-2030 年全球预测

Bone Morphogenetic Protein Market by Type (rhBMP-2, rhBMP-7), Application (Oral Maxillofacial, Reconstruction, Spinal fusion) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 180 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年骨形成蛋白市值为16.3亿美元，预计2024年将达到18.8亿美元，复合年增长率为14.81%，预计到2030年将达到43.1亿美元。

骨形成蛋白(BMP) 是一组已知在骨骼和软骨形成中发挥重要作用的生长因子。对 BMP 的需求在于其在整形外科手术、脊椎融合手术和牙科治疗中的应用，以促进骨骼生长和癒合。对 BMP 的需求延伸到医疗和牙科领域，凸显了它们从骨骼修復到组织工程的广泛应用。市场洞察预测，骨骼相关疾病增加、人口老化和再生医学进步将推动积极成长。此外，重组DNA技术等技术创新正在扩大BMP的治疗应用。

主要市场统计
基准年[2023] 16.3亿美元
预测年份 [2024] 18.8亿美元
预测年份 [2030] 43.1亿美元
复合年增长率（%） 14.81%

主要的成长要素包括生物技术的进步和医疗保健支出的增加以及全球移植骨替代物市场的扩大。然而，潜在的挑战包括高昂的治疗成本、严格的法律规范以及副作用的风险，例如不必要的骨骼生长。在快速成长的经济体中，未满足的需求创造了商机，这些经济体的整形外科和牙科手术呈上升趋势。公司可以透过利用与研究机构的策略伙伴关係关係来增加产品平臺和市场占有率。此外，推出具有成本效益的 BMP 为基础的产品可能会开拓新的市场。

创新和研究可以专注于开发副作用较少的 BMP 配方，并改善输送系统以提高功效和安全性。个人化医疗，即根据患者个别情况客製化 BMP 的使用，以达到最佳效果，这也是一个创新的成熟领域。儘管市场竞争激烈，但它是一个充满活力的市场，透过解决限制和利用新技术，具有成长潜力。投资于强大的研发、策略性地域扩张和技术整合的公司最有可能充分利用市场潜力。长期成功取决于平衡技术创新与监管条件和承受能力，以在充满挑战的医疗保健环境中维持成长。

市场动态：揭示快速发展的骨形成蛋白市场的关键市场洞察

供需的动态交互作用正在改变骨形成蛋白市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时也能帮助企业了解消费行为及其对製造业的影响。

  • 市场驱动因素
    • 运动相关伤害和脊椎融合手术的发生率上升
    • 人们对骨形成蛋白的认识不断增强
    • 骨生成激素在口腔颚颜面骨缺损临床治疗的应用
  • 市场限制因素
    • 治疗费用高
  • 市场机会
    • 对微创医疗程序的需求不断增长
    • 外伤治疗方法的进展
  • 市场挑战
    • 替代疗法和产品的可用性，例如骨移植物和支架；

波特五力：驾驭骨形成蛋白市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解外在对骨形成蛋白市场的影响

外部宏观环境因素在塑造骨形成蛋白市场的表现动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解骨形成蛋白市场的竞争格局

对骨形成蛋白市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV定位骨形成蛋白市场供应商绩效评估

FPNV定位矩阵是评估骨形成蛋白市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议描绘了骨形成蛋白市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，对骨形成蛋白市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监管核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 运动相关伤害和脊椎融合手术的发生率上升
      • 提高对骨形成蛋白的认识
      • 骨形成蛋白在临床口腔颚颜面骨缺损治疗的应用
    • 抑制因素
      • 手续成本高
    • 机会
      • 对微创医疗程序的需求增加
      • 创伤治疗线的进展
    • 任务
      • 替代疗法和产品的可用性，例如骨移植物和支架；
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章骨形成蛋白市场：依类型

  • 重组HBMP-2基因
  • 重组HBMP-7基因

第七章骨形成蛋白市场：依应用分类

  • 口腔颚颜面
  • 重建
  • 脊椎融合手术
  • 创伤

第八章美洲骨形成蛋白市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第九章亚太骨形成蛋白市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十章欧洲/中东/非洲骨形成蛋白市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十一章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Akron Biotechnology, LLC
  • AlloSource, Inc.
  • Bioventus LLC
  • Cellumed Co. Ltd
  • Ember Therapeutics Inc.
  • Hangzhou Jiuyuan Gene Engineering Co .,Ltd
  • HiMedia Laboratories
  • Integra Lifesciences Corporation
  • Johnson & Johnson Services Inc.
  • Medtronic PLC
  • Merck KGaA
  • Olympus Corporation
  • Orthofix Holdings, Inc.
  • Pfizer, Inc.
  • Prospec-Tany Technogene Ltd.
  • R&D Systems, Inc.
  • ScienCell Research Laboratories, Inc.
  • Sino Biological Inc.
  • Smith & Nephew PLC
  • Stryker Corporation
  • Thermo Fisher Scientific, Inc
  • Xtant Medical Holdings, Inc
  • Zimmer Biomet Holdings, Inc.
Product Code: MRR-ED54C46E81E8

The Bone Morphogenetic Protein Market was valued at USD 1.63 billion in 2023, expected to reach USD 1.88 billion in 2024, and is projected to grow at a CAGR of 14.81%, to USD 4.31 billion by 2030.

Bone Morphogenetic Proteins (BMPs) are a group of growth factors known for their critical role in the formation of bone and cartilage. The necessity of BMPs lies in their application in orthopedic surgeries, spinal fusions, and dental procedures to promote bone growth and healing. The demand for BMPs extends across medical and dental fields, emphasizing their application scope ranging from bone repair to tissue engineering. Market insight indicates a positive growth trajectory fueled by increasing incidences of bone-related disorders, an aging population, and advancements in regenerative medicine. Further, technological innovations, including recombinant DNA technology, have expanded BMPs' therapeutic use.

KEY MARKET STATISTICS
Base Year [2023] USD 1.63 billion
Estimated Year [2024] USD 1.88 billion
Forecast Year [2030] USD 4.31 billion
CAGR (%) 14.81%

Key growth influencers are advances in biotechnology and increasing healthcare expenditure alongside an expanding global market for bone graft substitutes. However, potential challenges include high treatment costs, strict regulatory frameworks, and the risk of adverse side effects, such as unwanted bone growth. Opportunities emerge from unmet needs in rapidly growing economies with increasing orthopedic and dental procedure rates. Companies could capitalize on strategic partnerships with research institutions to enhance product pipelines and market presence. Moreover, the introduction of cost-effective BMP-based products could open up new markets.

Innovation and research can focus on creating BMP variants with lower side-effect profiles and enhancing delivery systems to improve efficacy and safety. Another area ripe for innovation is personalized medicine, aligning BMP use with individual patient profiles for optimized results. The market, while competitive, remains dynamic, with potential for growth through addressing constraints and leveraging emerging technologies. Companies investing in robust R&D, strategic geographic expansions, and technology integration are best positioned to harness market potentials. Long-term success will depend on balancing innovation with regulatory compliance and affordability to sustain growth in a challenging healthcare landscape.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Bone Morphogenetic Protein Market

The Bone Morphogenetic Protein Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising prevalence rate of sports-related injuries and spinal fusion procedure
    • Increasing awareness regarding the bone morphogenetic protein
    • Application of bone morphogenetic proteins in the treatment of clinical oral and maxillofacial osseous defects
  • Market Restraints
    • High cost of the procedure
  • Market Opportunities
    • Growing demand for minimally invasive medical procedures
    • Developing advancements in treatment lines for traumatic injuries
  • Market Challenges
    • Availability of the substitute treatment and products such as bone grafts and scaffolds

Porter's Five Forces: A Strategic Tool for Navigating the Bone Morphogenetic Protein Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Bone Morphogenetic Protein Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Bone Morphogenetic Protein Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Bone Morphogenetic Protein Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Bone Morphogenetic Protein Market

A detailed market share analysis in the Bone Morphogenetic Protein Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Bone Morphogenetic Protein Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Bone Morphogenetic Protein Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Bone Morphogenetic Protein Market

A strategic analysis of the Bone Morphogenetic Protein Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Bone Morphogenetic Protein Market, highlighting leading vendors and their innovative profiles. These include Akron Biotechnology, LLC, AlloSource, Inc., Bioventus LLC, Cellumed Co. Ltd, Ember Therapeutics Inc., Hangzhou Jiuyuan Gene Engineering Co .,Ltd, HiMedia Laboratories, Integra Lifesciences Corporation, Johnson & Johnson Services Inc., Medtronic PLC, Merck KGaA, Olympus Corporation, Orthofix Holdings, Inc., Pfizer, Inc., Prospec-Tany Technogene Ltd., R&D Systems, Inc., ScienCell Research Laboratories, Inc., Sino Biological Inc., Smith & Nephew PLC, Stryker Corporation, Thermo Fisher Scientific, Inc, Xtant Medical Holdings, Inc, and Zimmer Biomet Holdings, Inc..

Market Segmentation & Coverage

This research report categorizes the Bone Morphogenetic Protein Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across rhBMP-2 and rhBMP-7.
  • Based on Application, market is studied across Oral Maxillofacial, Reconstruction, Spinal fusion, and Trauma.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising prevalence rate of sports-related injuries and spinal fusion procedure
      • 5.1.1.2. Increasing awareness regarding the bone morphogenetic protein
      • 5.1.1.3. Application of bone morphogenetic proteins in the treatment of clinical oral and maxillofacial osseous defects
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of the procedure
    • 5.1.3. Opportunities
      • 5.1.3.1. Growing demand for minimally invasive medical procedures
      • 5.1.3.2. Developing advancements in treatment lines for traumatic injuries
    • 5.1.4. Challenges
      • 5.1.4.1. Availability of the substitute treatment and products such as bone grafts and scaffolds
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Bone Morphogenetic Protein Market, by Type

  • 6.1. Introduction
  • 6.2. rhBMP-2
  • 6.3. rhBMP-7

7. Bone Morphogenetic Protein Market, by Application

  • 7.1. Introduction
  • 7.2. Oral Maxillofacial
  • 7.3. Reconstruction
  • 7.4. Spinal fusion
  • 7.5. Trauma

8. Americas Bone Morphogenetic Protein Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Bone Morphogenetic Protein Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Bone Morphogenetic Protein Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Akron Biotechnology, LLC
  • 2. AlloSource, Inc.
  • 3. Bioventus LLC
  • 4. Cellumed Co. Ltd
  • 5. Ember Therapeutics Inc.
  • 6. Hangzhou Jiuyuan Gene Engineering Co .,Ltd
  • 7. HiMedia Laboratories
  • 8. Integra Lifesciences Corporation
  • 9. Johnson & Johnson Services Inc.
  • 10. Medtronic PLC
  • 11. Merck KGaA
  • 12. Olympus Corporation
  • 13. Orthofix Holdings, Inc.
  • 14. Pfizer, Inc.
  • 15. Prospec-Tany Technogene Ltd.
  • 16. R&D Systems, Inc.
  • 17. ScienCell Research Laboratories, Inc.
  • 18. Sino Biological Inc.
  • 19. Smith & Nephew PLC
  • 20. Stryker Corporation
  • 21. Thermo Fisher Scientific, Inc
  • 22. Xtant Medical Holdings, Inc
  • 23. Zimmer Biomet Holdings, Inc.

LIST OF FIGURES

  • FIGURE 1. BONE MORPHOGENETIC PROTEIN MARKET RESEARCH PROCESS
  • FIGURE 2. BONE MORPHOGENETIC PROTEIN MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL BONE MORPHOGENETIC PROTEIN MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. BONE MORPHOGENETIC PROTEIN MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. BONE MORPHOGENETIC PROTEIN MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. BONE MORPHOGENETIC PROTEIN MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL BONE MORPHOGENETIC PROTEIN MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. BONE MORPHOGENETIC PROTEIN MARKET DYNAMICS
  • TABLE 7. GLOBAL BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY RHBMP-2, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY RHBMP-7, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY ORAL MAXILLOFACIAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY RECONSTRUCTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY SPINAL FUSION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TRAUMA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. AMERICAS BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 16. AMERICAS BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 17. AMERICAS BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 18. ARGENTINA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 19. ARGENTINA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 20. BRAZIL BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 21. BRAZIL BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 22. CANADA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 23. CANADA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 24. MEXICO BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 25. MEXICO BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 26. UNITED STATES BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 27. UNITED STATES BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 28. UNITED STATES BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 29. ASIA-PACIFIC BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. ASIA-PACIFIC BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 31. ASIA-PACIFIC BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 32. AUSTRALIA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. AUSTRALIA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 34. CHINA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. CHINA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 36. INDIA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. INDIA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 38. INDONESIA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. INDONESIA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 40. JAPAN BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. JAPAN BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 42. MALAYSIA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. MALAYSIA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 44. PHILIPPINES BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. PHILIPPINES BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 46. SINGAPORE BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. SINGAPORE BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 48. SOUTH KOREA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. SOUTH KOREA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 50. TAIWAN BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. TAIWAN BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. THAILAND BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. THAILAND BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 54. VIETNAM BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. VIETNAM BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 56. EUROPE, MIDDLE EAST & AFRICA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. EUROPE, MIDDLE EAST & AFRICA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 58. EUROPE, MIDDLE EAST & AFRICA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 59. DENMARK BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. DENMARK BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. EGYPT BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. EGYPT BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 63. FINLAND BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. FINLAND BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. FRANCE BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. FRANCE BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. GERMANY BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. GERMANY BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. ISRAEL BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. ISRAEL BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. ITALY BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. ITALY BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 73. NETHERLANDS BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. NETHERLANDS BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. NIGERIA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. NIGERIA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. NORWAY BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. NORWAY BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 79. POLAND BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. POLAND BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. QATAR BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. QATAR BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 83. RUSSIA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. RUSSIA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 85. SAUDI ARABIA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. SAUDI ARABIA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH AFRICA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH AFRICA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. SPAIN BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. SPAIN BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 91. SWEDEN BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. SWEDEN BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. SWITZERLAND BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. SWITZERLAND BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 95. TURKEY BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. TURKEY BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. UNITED ARAB EMIRATES BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED ARAB EMIRATES BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED KINGDOM BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. UNITED KINGDOM BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 101. BONE MORPHOGENETIC PROTEIN MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 102. BONE MORPHOGENETIC PROTEIN MARKET, FPNV POSITIONING MATRIX, 2023